A Study of Niraparib in Patients With Relapsed Ovarian Cancer

NCT04392102 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Zai Lab (Shanghai) Co., Ltd.